FDA accepts Iroko's Zorvolex sNDA for review
The US Food and Drug Administration (FDA) is to review Iroko Pharmaceuticals' supplemental new drug application (sNDA) for ZORVOLEX (diclofenac), a lower dose nonsteroidal anti-inflammatory drug (NSAID) for treating osteoarthritis pain in adults. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - January 16, 2014 Category: Pharmaceuticals Source Type: news
Pro ArthMax by Human Science Foundation: Recall - Undeclared Drug Ingredients
Undeclared Chlorzoxazone, Nefopam, Diclofenac, Ibuprofen, Naproxen, and Indomethacin. Pro ArthMax has a reasonable probability of resulting in fatal adverse events. (Source: FDA MedWatch)
Source: FDA MedWatch - January 14, 2014 Category: American Health Source Type: news
Best Thing I’ve Done! – Lindsay’s Story
I am writing this story to let ladies know that having a hysterectomy may not be as bad as you imagine. I have suffered with painful, heavy periods since I was a teenager. I am now 46 years old and married with two children and have never had a confirmed diagnosis, although most doctors saying it was endometriosis. Over the years I have tried various treatments such as D & C’s, thermal ablation and injections into my stomach to shrink the endometriosis.
Nothing has really worked but I have always avoided having a hysterectomy as I am petrified of hospitals, needles and anesthesia. My patient husband and children...
Source: The Hysterectomy Association - November 13, 2013 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Your Stories endometriosis heavy bleeding pms Source Type: news
Best Thing I ’ ve Done! – Lindsay ’ s Story
I am writing this story to let ladies know that having a hysterectomy may not be as bad as you imagine. I have suffered with painful, heavy periods since I was a teenager. I am now 46 years old and married with two children and have never had a confirmed diagnosis, although most doctors saying it was endometriosis. Over the years I have tried various treatments such as D & C’s, thermal ablation and injections into my stomach to shrink the endometriosis.
Nothing has really worked but I have always avoided having a hysterectomy as I am petrified of hospitals, needles and anesthesia. My patient husband and children...
Source: The Hysterectomy Association - November 13, 2013 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Health endometriosis heavy bleeding hysterectomy stories pms Source Type: news
Best Thing I ’ ve Done! – Lindsay ’ s Story
I am writing this story to let ladies know that having a hysterectomy may not be as bad as you imagine. I have suffered with painful, heavy periods since I was a teenager. I am now 46 years old and married with two children and have never had a confirmed diagnosis, although most doctors saying it was endometriosis. Over the years I have tried various treatments such as D & C’s, thermal ablation and injections into my stomach to shrink the endometriosis.
Nothing has really worked but I have always avoided having a hysterectomy as I am petrified of hospitals, needles and anesthesia. My patient husband and children...
Source: The Hysterectomy Association - November 13, 2013 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Health endometriosis heavy bleeding hysterectomy stories pms Source Type: news
Zorvolex (Diclofenac Capsules) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 31, 2013 Category: Drugs & Pharmacology Source Type: news
Iroko Pharmaceuticals Receives FDA Approval for ZORVOLEX™
Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, has announced that the U.S. Food and Drug Administration (FDA) has approved ZORVOLEX™ (diclofenac) capsules, a nonsteroidal anti-inflammatory drug (NSAID), for the treatment of mild to moderate acute pain in adults[i]. ZORVOLEX was approved at dosage strengths that are 20 percent lower than currently available diclofenac products... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 22, 2013 Category: Consumer Health News Tags: Pain / Anesthetics Source Type: news
Submicron Diclofenac Reduces Postsurgical PainSubmicron Diclofenac Reduces Postsurgical Pain
The submicron particle formulation allows for a lower dose of the NSAID, but cardiovascular risks still a concern for some. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 16, 2013 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
Investigational submicron diclofenac reduces use of opioid rescue medication in post-surgical pain in a Phase 3 study
Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, has announced that the company's investigational, non-steroidal anti-inflammatory drug (NSAID) submicron diclofenac reduced the use of opioid rescue medication in patients with acute pain following bunionectomy surgery. Specifically, the study showed that significantly fewer patients who received submicron particle diclofenac capsules 35 mg (82 percent; P = 0.002) or 18 mg (85 percent; P = 0.005), or who received active comparator celecoxib (85 percent; P = 0... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 9, 2013 Category: Consumer Health News Tags: Pain / Anesthetics Source Type: news
Study demonstrates homeopathic Traumeel® as effective treatment option for musculoskeletal disorders
A recent study shows that Traumeel®, a topical pain medicine made of 12 natural ingredients (out of 14 actives), is as effective as a current standard therapy, 1% diclofenac gel, in reducing pain and improving function in adults with ankle sprain injuries. The findings, from the Traumeel® in Acute Ankle Sprain Study (TAASS), were recently highlighted in the online International Journal of Clinical Practice as well as an issue of Current Medical Research and Opinion,[1] and first reported at the European League Against Rheumatism (EULAR) conference in June 2012... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 3, 2013 Category: Consumer Health News Tags: Pain / Anesthetics Source Type: news
Ortiga: Public Notification - Contains Hidden Drug Ingredient
FDA laboratory analysis confirmed that Ortiga contains the prescription drug
ingredient, diclofenac (an NSAID). (Source: FDA MedWatch)
Source: FDA MedWatch - August 22, 2013 Category: American Health Source Type: news
Public consultation on availability of diclofenac as a pharmacy medicine
The MHRA has launched a public consultation on the availability of diclofenac as a pharmacy medicine.
The RPS initial response states:
“The RPS supports maintaining wid (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - August 5, 2013 Category: Drugs & Pharmacology Source Type: news
Common Painkiller Linked To Heart Attack And Stroke, UK Warning
Common painkiller, diclofenac, raises the risk of heart attack and stroke among patients with serious underlying heart conditions, the UK's Medicines and Healthcare Products Regulatory Agency (MHRA) has warned. MHRA specifies that patients with circulatory problems, heart disease, heart failure, or a previous stroke or heart attack should stop using diclofenac. Diclofenac is known under several trade names, including Diclomax, Defenac, Diclofex, Dyloject, Econac, Enstar, Flamrase, Flamatak, Motifene, Rheumatac, Rhumalgan, Volsaid, and Voltarol... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 1, 2013 Category: Consumer Health News Tags: Pain / Anesthetics Source Type: news
Heart risk warning over painkiller
People with heart problems are advised advised to stop using one of the most commonly prescribed anti-inflammatory drugs in the UK, diclofenac. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - June 29, 2013 Category: Consumer Health News Source Type: news
